Le Lézard
Classified in: Environment, Science and technology
Subjects: PDT, ENI, ESG

CropX Technologies helps farmers understand pending nitrogen regulations

TEL AVIV, Israel, July 25, 2022 /PRNewswire/ -- CropX Technologies, a global leader in digital agronomic solutions for farming operations, recently offered farmers in the Netherlands greater insight into how the government's new proposed nitrogen emission reductions will affect their farms. This helps farmers understand and prepare for the impact it will have on their operations and gives members of the general public and policymakers an easier way to understand the proposed nitrogen targets.

Nitrogen is a vital nutrient for crop and pasture growth but causes ecological problems when too much is released into the environment. In the Netherlands, manure from dairy operations is a significant source of emissions and is the focus of a government plan for emission reductions across the country.

CropX operates the precision mapping tool Boer&Bunder (www.boerenbunder.nl), which takes publicly available data on agricultural fields and makes it accessible in an online mapping platform. After the Dutch government released its map of proposed reduction targets, CropX quickly made it available to the public on Boer&Bunder as part of its free tier of access. Users can search specific field plots to see proposed reduction targets for each location.

"Making the Dutch government's nitrogen reduction map accessible helps everyone understand better the emission standards that could affect how farms are run in the foreseeable future," says Gert Sterenborg, Product Manager at CropX.

Boer&Bunder gives users insights into agricultural fields within the countries that it covers, currently the Netherlands, Belgium, Luxembourg, Denmark, Austria, France and two states in Germany. This includes field by field data on historic crop rotations and precise field plotting for planning and invoicing. Users can also access elevation maps and satellite imagery and have access to different data sets based on subscription tiers.

About CropX
CropX is one of the fastest growing providers of agribusiness farm management solutions in the world, deployed in over 50 countries and across all the arable continents. The CropX platform synthesizes data from the earth and sky to offer advanced soil and crop intelligence and a suite of digital decision and planning tools, all on an easy-to-use app capable of tracking multiple farms and fields. CropX is backed by the world's leading agribusinesses and VCs, who recognize that CropX's precision-ag technologies set new standards of best practices for environmental sustainability and greater farm productivity. Learn more at https://www.cropx.com

Photo - https://mma.prnewswire.com/media/1865944/CropX.jpg
Logo - https://mma.prnewswire.com/media/1751720/CropX_Logo.jpg

Media Contact
Hanna Day-Woodruff
Marketing and Communications Specialist
[email protected] 


These press releases may also interest you

at 19:05
Touchlight, a biotechnology company pioneering enzymatic DNA production to enable the genetic medicine revolution, is furthering pre-clinical development of its proprietary doggybone DNA vaccine platform, financed by a new grant received from the...

at 19:00
Smashing its records year by year, Lithuania's startup ecosystem has proved that there're no limits to growth. According to Dealroom.co, over the last five years, it has accelerated 16,6 times and is now valued at 10 billion EUR, placing Lithuania as...

at 18:53
S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600 effective prior to the opening of trading on Thursday, December 1: Nexstar Media Group Inc. (NASD:NXST) will replace Sabre Corp. (NASD:SABR) in the S&P...

at 18:46
DURECT Corporation , a biopharmaceutical company focused on developing epigenetic regulator programs for the treatment of acute organ injury and chronic liver diseases, announced that DURECT's board of directors today determined that the Company will...

at 18:45
ALZpath, Inc. announced today the launch of its first diagnostic assay for detection of phosphorylated tau 217...

at 18:30
Neurelis, Inc., a commercial-stage neuroscience company focused on the development and commercialization of therapeutics for the treatment of epilepsy and orphan neurologic disorders characterized by high unmet medical need, today announced that...

News published on 25 july 2022 at 15:29 and distributed by: